GlassScriptPhysician profile
Riaz Sirajuddin
NPI 1235186099
$291,065.27
in general payments reported to CMS, 2019-2025
41 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,808 · 2020: $15K · 2021: $29K · 2022: $110K · 2023: $54K · 2024: $38K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $110K · Travel and Lodging: $9,361 · Food and Beverage: $8,393 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109,994.92 |
| Travel and Lodging | $9,361.36 |
| Food and Beverage | $8,392.92 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $209,415.94 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Esperion Therapeutics, INC. | $33,009.97 | 2020-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $22,592.62 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $7,901.47 | 2019-2025 | Leqvio |
| Medtronic, INC. | $3,245.83 | 2021-2025 | Mycarelink, Micra, Selectsecure |
| Astrazeneca Pharmaceuticals LP | $2,736.76 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Amgen INC. | $2,159.84 | 2019-2025 | Repatha, Repatha |
| Cvrx, INC. | $1,774.48 | 2022-2025 | Barostim Neo System |
| Pfizer INC. | $1,275.31 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $995.59 | 2019-2024 | Livalo, Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $779.74 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $725.84 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $685.34 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $651.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $507.56 | 2019-2025 | Verquvo |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $333.79 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Arbor Pharmaceuticals, INC. | $315.37 | 2019-2022 | |
| Medtronic Vascular, INC. | $281.21 | 2019-2020 | |
| Abbott Laboratories | $249.00 | 2020-2025 | Aveir, Mitraclip, Cardiomems |
| Fisher & Paykel Healthcare INC | $189.00 | 2021 | |
| Baxter Healthcare | $163.91 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $146.88 | 2023-2025 | Extended Holter, (Ck4) Mcot |
| Impulse Dynamics (USA) INC. | $143.54 | 2023-2024 | Optimizer, Optimizer |
| Alnylam Pharmaceuticals INC. | $116.58 | 2023-2025 | Onpattro, Amvuttra |
| Sanofi-Aventis U.S. LLC | $115.38 | 2019 | |
| Atricure, INC. | $91.57 | 2022-2024 | |
| Scpharmaceuticals INC. | $81.24 | 2023-2025 | |
| Azurity Pharmaceuticals, INC. | $52.81 | 2024 | Edarbyclor |
| Edwards Lifesciences Corporation | $48.50 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $38.43 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.40 | 2025 | Lifevest |
| Althera Pharmaceuticals LLC | $33.29 | 2022 | |
| Boston Scientific Corporation | $30.16 | 2019-2025 | Watchman Flx |
| Allergan, INC. | $26.82 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $21.09 | 2023 | Arcalyst |
| Gilead Sciences, INC. | $20.66 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.30 | 2023 | Inpefa |
| Chiesi USA, INC. | $16.45 | 2024 | Kengreal, Cleviprex |
| Irhythm Technologies, INC. | $16.23 | 2021 | |
| Medicure Pharma INC. | $15.61 | 2024 | Zypitamag |
| Bardy Diagnostics, INC. | $7.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riaz Sirajuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.